OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE (Solco Healthcare US, LLC)
Welcome to the PulseAid listing for the OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE drug offered from Solco Healthcare US, LLC. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Solco Healthcare US, LLC |
| NON-PROPRIETARY NAME: | olmesartan medoxomil and hydrochlorothiazide |
| SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-24 |
| END MARKETING DATE: | 0000-00-00 |
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE HUMAN PRESCRIPTION DRUG Details:
| Item Description | OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE from Solco Healthcare US, LLC |
| LABELER NAME: | Solco Healthcare US, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2017-04-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 43547-391_cd558c7f-abb9-4785-a72b-68ce4a40705d |
| PRODUCT NDC: | 43547-391 |
| APPLICATION NUMBER: | ANDA207804 |
Other OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
